Post-Lithotripsy Protocol for ESWL
According to the most recent European Association of Urology guidelines, antimicrobial prophylaxis is not recommended for extracorporeal shock wave lithotripsy (ESWL), but post-procedure monitoring for complications and adjunctive therapies to enhance stone passage are essential components of care. 1
Post-ESWL Monitoring and Management
Immediate Post-Procedure Care
- Pain management: Non-opioid analgesics like diclofenac are effective for most patients undergoing ESWL 2
- Hydration: Encourage increased fluid intake to facilitate stone fragment passage
- Activity: Normal activity can be resumed, with no specific restrictions required
Adjunctive Therapies
- Medical expulsive therapy (MET): Alpha-blockers should be prescribed after ESWL to facilitate passage of stone fragments 1
- Mechanical percussion: Can be used as an adjunct to enhance stone passage 1
- Diuretics: May be considered to increase urine flow and aid fragment elimination 1
Monitoring for Complications
Common Complications to Monitor
- Steinstrasse (stone street): Occurs in approximately 4% of cases 1
- Macroscopic hematuria: Common (17.2%) and typically self-limiting 1
- Pain: Occurs in about 12.1% of patients 1
- Renal colic: Occurs in 2-4% of patients 1
- Infectious complications:
- Bacteriuria in non-infection stones (7.7-23%)
- Sepsis (0.15%) 1
Rare but Serious Complications
- Symptomatic hematoma: Occurs in 0.21% of cases 1
- Asymptomatic hematoma: Occurs in 1.2% of cases 1
- Cardiovascular effects: Dysrhythmias can occur in 11-29% of patients 1
Follow-up Protocol
Imaging Follow-up
- Imaging should be performed to assess stone clearance
- The timing depends on stone size and location, typically 2-4 weeks post-procedure
Indications for Additional Intervention
- Persistent obstruction
- Significant residual fragments (>4mm)
- Infection
- Intractable pain
Special Considerations
Antibiotic Prophylaxis
- According to the 2024 EAU guidelines, antimicrobial prophylaxis is not recommended for ESWL 1
- However, for patients with specific risk factors (positive preoperative urine culture, indwelling nephrostomy tube or stent, history of recurrent UTIs, or immunocompromised status), antibiotic prophylaxis should be considered 3
Stenting Considerations
- Routine stenting before ESWL is not recommended as it does not improve stone-free rates 1
- However, stenting may be beneficial in reducing steinstrasse formation 1
Clinical Pitfalls to Avoid
- Failure to recognize steinstrasse: Monitor for signs of obstruction and intervene promptly
- Inadequate pain management: Some patients may require stronger analgesia than initially anticipated
- Missing infectious complications: Watch for fever, chills, or increasing pain which may indicate infection
- Overlooking residual fragments: Fragments can lead to stone regrowth (21-59% of cases) 1
- Ignoring cardiovascular symptoms: Especially in patients with pre-existing cardiac conditions
By following this protocol, clinicians can optimize outcomes after ESWL while minimizing complications and the need for additional interventions.